T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53
Japan
2023-568469
Filed on 2023-11-06
2023-568469
Filed on 2023-11-06
METHODS OF IDENTIFYING TARGETS OF CANCER DRUGS
AND OF TREATING CANCER
Patent Cooperation Treaty
PCT/US2023/076704
Filed on 2023-10-12
PCT/US2023/076704
Filed on 2023-10-12
Glypican 2 As A Cancer Marker And Therapeutic Target
Japan
2023-133443
Filed on 2016-11-08
2023-133443
Filed on 2016-11-08
Directed acetylation of mRNA through engineered snoRNA adapters
Patent Cooperation Treaty
PCT/US2023/078830
Filed on 2023-11-06
PCT/US2023/078830
Filed on 2023-11-06
TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES
Patent Cooperation Treaty
PCT/US2023/081638
Filed on 2023-11-29
PCT/US2023/081638
Filed on 2023-11-29
Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines
Patent Cooperation Treaty
PCT/US2023/082186
Filed on 2023-12-01
PCT/US2023/082186
Filed on 2023-12-01
CANCER VACCINE AND METHOD OF USE THEREOF
US Application 18/550,895
Filed on 2023-09-15
Filed on 2023-09-15
IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OFCANCER AND MYELOID-MEDIATED DISEASES
Patent Cooperation Treaty
PCT/US2023/078854
Filed on 2023-11-06
PCT/US2023/078854
Filed on 2023-11-06
T CELL RECEPTORS RECOGNIZING MUTATED P53
Eurasian Patent
202392526
Filed on 2023-10-06
202392526
Filed on 2023-10-06